Baseline demographics and proportion of patients reporting symptoms in a follow-up clinic visit, >3 months after acute COVID-19-infection
| . | Patients analyzed . |
|---|---|
| Female/male | 197 (60); 133 (40) |
| Median age | 46 y (range, 18-88) |
| Median time (mo) from acute COVID-19 infection | 6 (range, 4-10) |
| Symptomatic patients | 319 (97) |
| Respiratory symptoms (breathlessness, cough) | 223 (68) |
| Fatigue | 239 (72) |
| Neurological symptoms (headaches, numbness), cognitive impairment (poor memory/concentration), postural symptoms (disturbed sleep, dizziness/light headedness) | 153 (46) |
| Cardiac symptoms (chest discomfort, palpitations) | 155 (47) |
| Rheumatological symptoms (arthralgia, myalgia) | 79 (24) |
| Abdominal symptoms (abdominal pain, nausea/vomiting, diarrhea/constipation) | 39 (12) |
| Other (rash, anosmia, sore throat, splinter hemorrhages) | 45 (14) |
| . | Patients analyzed . |
|---|---|
| Female/male | 197 (60); 133 (40) |
| Median age | 46 y (range, 18-88) |
| Median time (mo) from acute COVID-19 infection | 6 (range, 4-10) |
| Symptomatic patients | 319 (97) |
| Respiratory symptoms (breathlessness, cough) | 223 (68) |
| Fatigue | 239 (72) |
| Neurological symptoms (headaches, numbness), cognitive impairment (poor memory/concentration), postural symptoms (disturbed sleep, dizziness/light headedness) | 153 (46) |
| Cardiac symptoms (chest discomfort, palpitations) | 155 (47) |
| Rheumatological symptoms (arthralgia, myalgia) | 79 (24) |
| Abdominal symptoms (abdominal pain, nausea/vomiting, diarrhea/constipation) | 39 (12) |
| Other (rash, anosmia, sore throat, splinter hemorrhages) | 45 (14) |
Data are the number (percentage) of patients in the total study group (N = 330), unless otherwise indicated.